[1]王雨婵,李 莎,赵 新.血清微小RNA-34b、微小RNA-181c与急性缺血性脑卒中患者机械取栓治疗预后关系研究[J].陕西医学杂志,2025,54(5):640-644.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.013]
　WANG Yuchan,LI Sha,ZHAO Xin.Relationship between serum miR-34b,miR-181c and the prognosis of mechanical thrombectomy therapy in patients with acute ischemic stroke[J].,2025,54(5):640-644.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.013]
点击复制

血清微小RNA-34b、微小RNA-181c与急性缺血性脑卒中患者机械取栓治疗预后关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年5期
页码:
640-644
栏目:
临床研究
出版日期:
2025-05-05

文章信息/Info

Title:
Relationship between serum miR-34b,miR-181c and the prognosis of mechanical thrombectomy therapy in patients with acute ischemic stroke
作者:
王雨婵; 李 莎; 赵 新
(成都市第三人民医院康复医学科,四川 成都 610031)
Author(s):
WANG Yuchan; LI Sha; ZHAO Xin
(Department of Rehabilitation Medicine,the Third People's Hospital of Chengdu,Chengdu 610031,China)
关键词:
急性缺血性脑卒中;  微小RNA-34b;  微小RNA-181c;  机械取栓;  预后;  交互作用
Keywords:
Acute ischemic stroke;  miR-34b;  miR-181c;  Mechanical thrombectomy;  Prognosis;  Interaction
分类号:
R 743.3
DOI:
DOI:10.3969/j.issn.1000-7377.2025.05.013
文献标志码:
A
摘要:
目的:分析血清微小RNA(miR)-34b、miR-181c与急性缺血性脑卒中(AIS)患者机械取栓治疗预后的关系。方法:选取132例接受机械取栓治疗的AIS患者,于取栓前及取栓后3、7 d检测血清miR-34b、miR-181c水平,并根据出院后90 d随访预后情况分为预后良好组和预后不良组。采用Spearman法分析血清miR-34b、miR-181c水平与血清炎症因子水平及患者预后的相关性; 交互作用系数γ分析交互影响及作用类型; 血清miR-34b、miR-181c对AIS患者机械取栓治疗预后的预测价值通过绘制受试者工作特征(ROC)曲线进行分析。结果:随访90 d,132例AIS患者中失访4例,其余患者中87例(67.97%)患者预后良好,41例(32.03%)患者预后不良。取栓前及取栓后3、7 d,预后良好组血清miR-34b水平高于预后不良组,血清miR-181c水平低于预后不良组(均P<0.05)。取栓前及取栓后3、7 d,预后良好组血清白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)、IL-1β水平低于预后不良组(均P<0.05)。血清miR-34b水平与血清IL-10、TNF-α、IL-1β水平及患者预后呈负相关,血清miR-181c与血清IL-10、TNF-α、IL-1β水平及患者预后呈正相关(均P<0.05)。血清miR-34b低表达与miR-181c高表达呈正向交互作用,为次相乘模型。取栓前及取栓后3、7 d,miR-34b、miR-181c联合预测AIS患者机械取栓治疗预后不良的曲线下面积(AUC)大于两者分别单独预测的AUC,且取栓后7 d miR-34b、miR-181c联合预测的AUC最大(均P<0.05)。结论:血清miR-34b、miR-181c水平与AIS患者机械取栓治疗预后有关,miR-34b低表达与miR-181c高表达呈正向交互作用,两者联合检测对AIS患者机械取栓治疗预后有较高的预测效能。
Abstract:
Objective:To analyze the relationship between serum miR-34b,miR-181c and the prognosis of mechanical thrombectomy therapy in patients with acute ischemic stroke(AIS).Methods:A total of 132 patients with AIS who underwent mechanical thrombectomy were selected.Serum levels of miR-34b and miR-181c were detected before thrombectomy and at 3 and 7 days after thrombectomy.Patients were divided into good-prognosis and poor-prognosis groups based on the 90-day follow-up after discharge.Spearman correlation analysis was used to assess the correlation between serum miR-34b,miR-181c levels,serum inflammatory factors and patient prognosis.Interaction coefficient γ was used to analyze the interaction effects and types of interactions.Receiver operating characteristic(ROC)curves were plotted to analyze the predictive value of serum miR-34b and miR-181c for the prognosis of mechanical thrombectomy therapy in AIS patients.Results:During the 90-day follow-up,4 patients of 132 AIS patients were lost.Among the remaining patients,87(67.97%)had a good prognosis,and 41(32.03%)had a poor prognosis.Before thrombectomy and at 3 and 7 days after thrombectomy,serum miR-34b levels were higher in the good-prognosis group than in the poor-prognosis group,while serum miR-181c levels were lower(all P<0.05).Serum levels of interleukin-10(IL-10),tumor necrosis factor-α(TNF-α),and IL-1β were also lower in the good-prognosis group than in the poor-prognosis group before and at 3 and 7 days after thrombectomy(all P<0.05).Serum miR-34b levels were negatively correlated with serum IL-10,TNF-α,IL-1β levels and patient prognosis,while serum miR-181c levels were positively correlated(all P<0.05).Low expression of serum miR-34b and high expression of miR-181c showed a positive interaction effect,fitting a submultiplicative model.The combined prediction of miR-34b and miR-181c for poor prognosis in AIS patients undergoing mechanical thrombectomy had a larger AUC than individual predictions at all time points,with the highest AUC at 7 days after thrombectomy(all P<0.05).Conclusion:Serum levels of miR-34b and miR-181c are associated with the prognosis of mechanical thrombectomy therapy in AIS patients.Low expression of miR-34b and high expression of miR-181c show a positive interaction effect.Combined detection of these two miRNAs provides a higher predictive efficacy for the prognosis of mechanical thrombectomy therapy in AIS patients.

参考文献/References:

[1] JOLUGBO P,ARIËNS R A S.Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke[J].Stroke,2021,52(3):1131-1142.
[2] 李斌,王高临,韩桂浩,等.Solitaire AB支架机械取栓联合动脉溶栓治疗急性缺血性脑卒中疗效观察[J].陕西医学杂志,2024,53(6):806-809,813.
[3] 王晶晶,李斗,肖书丽.院前远隔缺血适应联合院内机械取栓治疗大血管闭塞性急性缺血性脑卒中的效果[J].实用心脑肺血管病杂志,2023,31(12):106-111.
[4] KANKI H,MATSUMOTO H,TOGAMI Y,et al.Importance of microRNAs by mRNA-microRNA integration analysis in acute ischemic stroke patients[J].J Stroke Cerebrovasc Dis,2023,32(9):107277.
[5] XIE H R,HUANG Y J,ZHAN Y L.Construction of a novel circRNA-miRNA-ferroptosis related mRNA network in ischemic stroke[J].Sci Rep,2023,13(1):15077.
[6] 李泓宇,兰瑞,付雪琴,等.miRNA在缺血性脑卒中神经保护领域的研究进展[J].中国比较医学杂志,2023,33(11):110-117.
[7] WEI G,LIAO C,JIAN C,et al.Evaluation of miR-34b/c polymorphisms to the risk of ischemic stroke[J].J Hypertens,2020,38(8):1481-1487.
[8] 秦树巧,黑丹丹.β-七叶皂苷钠辅助溶栓治疗对急性脑梗死病人血清miR-155与miR-181c表达的影响[J].中西医结合心脑血管病杂志,2022,20(16):3042-3044.
[9] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.缺血性卒中基层诊疗指南(2021年)[J].中华全科医师杂志,2021,20(9):927-946.
[10] 周佩莉,袁怀武,计仁杰,等.缺血性卒中急性期患者认知障碍症状学的分型[J].中国脑血管病杂志,2016,13(6):281-286.
[11] GAO M Z,LI Y,HO W,et al.Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization[J].ACS Nano,2024,18(4):3260-3275.
[12] ZHANG Z L,WANG Q H,ZHAO X L,et al.YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA[J].Cell Death Dis,2020,11(11):977.
[13] 古联,杨怡冰,严雁,等.缺血性脑卒中凋亡相关lncRNA-mRNA网络构建及核心基因预测[J].中国医药导报,2023,20(20):4-9.
[14] 王俐慧,苏东风,隋汝波.急性脑梗死患者血清miR-34b表达及检测临床意义[J].陕西医学杂志,2022,51(5):608-611,616.
[15] ZHANG W C,YANG J H,LIU G H,et al.MiR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH[J].Cell Cycle,2019,18(23):3263-3274.
[16] RYU C S,OH S H,LEE K O,et al.MiR-10a,27a,34b/c,and 300 polymorphisms are associated with ischemic stroke susceptibility and post-stroke mortality[J].Life(Basel),2020,10(12):309.
[17] MENG Q L,YE C X,LU Y Q.MiR-181c regulates ischemia/reperfusion injury-induced neuronal cell death by regulating c-Fos signaling[J].Pharmazie,2020,75(2):90-93.
[18] CAO D W,LIU M M,DUAN R,et al.The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation[J].Acta Pharmacol Sin,2020,41(1):22-33.
[19] BANAVATH H N,ROMAN B,MACKOWSKI N,et al.MiR-181c activates mitochondrial calcium uptake by regulating MICU1 in the heart[J].J Am Heart Assoc,2019,8(24):12919.
[20] 冯程程,朱瑞霞,何志义.脑梗死患者血清miR-181c、miR-21水平与颈动脉狭窄及其不良预后的相关性预测[J].西部医学,2022,34(6):851-855.
[21] 任海蓉,闫兰卓.丙氨酰-谷氨酰胺配合高压氧治疗对中青年缺血性脑卒中患者恢复期外周血T淋巴亚群及miR-124、miR-181c的影响[J].国际神经病学神经外科学杂志,2022,49(4):19-25.
[22] LI X L,ZHONG J C,ZENG Z,et al.MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway[J].Cardiovasc Diagn Ther,2020,10(4):849-858.
[23] DELONG J H,OHASHI S N,O'CONNOR K C,et al.Inflammatory responses after ischemic stroke[J].Semin Immunopathol,2022,44(5):625-648.
[24] 杨泳,杨惠卿.急性缺血性脑卒中中医常见证型血清学相关指标变化临床研究[J].陕西中医,2024,45(1):55-58,66.
[25] 姜艳,徐娟,胡臻华.急性脑梗死患者血清miR-151a-3p、miR-210水平变化及与炎症因子的关系[J].检验医学与临床,2022,19(9):1276-1278.
[26] NONG J,GLASSMAN P M,SHUVAEV V V,et al.Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke[J].Mol Ther,2024,32(5):1344-1358.
[27] LIU X,WANG Q W,ZHAO J J,et al.Inflammation-related circRNA polymorphism and ischemic stroke prognosis[J].J Mol Neurosci,2021,71(10):2126-2133.

相似文献/References:

[1]王俐慧,苏东风,隋汝波.急性脑梗死患者血清miR-34b表达及检测临床意义[J].陕西医学杂志,2022,51(5):608.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.022]
　WANG Lihui,SU Dongfeng,SUI Rubo.Expression of miR-34b in serum of patients with acute cerebral infarction and its clinical significance[J].,2022,51(5):608.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.022]
[2]李 斌,王高临,韩桂浩,等.Solitaire AB支架机械取栓联合动脉溶栓治疗急性缺血性脑卒中疗效观察[J].陕西医学杂志,2024,(6):806.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.018]
[3]张 磊,王宜兵,常 成,等.血清Hepc-25、SMAD3、IRAK4在急性缺血性脑卒中患者血管介入治疗术后脑出血转化中的水平变化及检测意义[J].陕西医学杂志,2024,(11):1548.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.024]
[4]王 萌,杜俊秋.急性缺血性脑卒中相关性肺炎危险因素分析及急性缺血性脑卒中相关分析评分的预测价值[J].陕西医学杂志,2025,54(1):97.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.019]
　WANG Meng,DU Junqiu.Analysis of risk factors for acute ischemic stroke-associated pneumonia and the predictive value of AIS-APS score[J].,2025,54(5):97.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.019]

备注/Memo

备注/Memo:
[基金项目]四川省医学(青年创新)科研课题(S211273)
更新日期/Last Update: 2025-05-05